Table 4_Hekun decoction versus Femoston for women with amnestic mild cognitive impairment in early menopause: a randomized, three-arm, double-blind clinical trial.docx

Background<p>Amnestic mild cognitive impairment (aMCI), a prodromal stage of Alzheimer’s disease (AD), carries a high risk of progression to dementia. However, few clinical trials have focused on interventions to delay this progression. Hekun Decoction, an herbal-based oral medicine, has shown...

Täydet tiedot

Tallennettuna:

Bibliografiset tiedot
Päätekijä:	Ziqi Zhai (18055509) (author)
Muut tekijät:	Guangyao Lin (15270472) (author), Siru Chen (12535119) (author), Huicong Liu (1513414) (author), Rui Yuan (615737) (author), Xianwei Gao (22234654) (author), Xiaorong Ni (17830436) (author), Mingjie Shen (9379710) (author), Haiying Fan (267645) (author), Wenjun Wang (314231) (author), Yan Zhao (58882) (author), Yan Wu (70890) (author), Chao Gu (402478) (author), Chao Cong (14577518) (author), Shan Xiao (3117867) (author), Yue Zhang (30585) (author), Jingchang Zhao (9192073) (author), Jiayao Xu (1421440) (author), Ye Wang (41998) (author), Jie Chen (5892) (author), Yishuang Chen (22234657) (author), Yan Zong (6274541) (author), Qianjue Tang (22234660) (author), Shengnan Li (345816) (author), Zhijie Zhang (227551) (author), Lianwei Xu (16857051) (author)
Julkaistu:	2025
Aiheet:	Neurology and Neuromuscular Diseases amnestic mild cognitive impairment Hekun decoction early menopausal women Alzheimer’s disease clinical trial
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!

Table 4_Hekun decoction versus Femoston for women with amnestic mild cognitive impairment in early menopause: a randomized, three-arm, double-blind clinical trial.docx

Samankaltaisia teoksia